1. Home
  2. HRB vs ROIV Comparison

HRB vs ROIV Comparison

Compare HRB & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H&R Block Inc.

HRB

H&R Block Inc.

N/A

Current Price

$45.34

Market Cap

5.7B

ML Signal

N/A

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$40.14

Market Cap

25.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HRB
ROIV
Founded
1955
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
25.1B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
HRB
ROIV
Price
$45.34
$40.14
Analyst Decision
Sell
Strong Buy
Analyst Count
2
9
Target Price
$41.00
$28.94
AVG Volume (30 Days)
1.5M
8.2M
Earning Date
05-06-2026
05-28-2026
Dividend Yield
5.34%
N/A
EPS Growth
28.93
N/A
EPS
5.66
N/A
Revenue
$3,159,931,000.00
$8,260,000.00
Revenue This Year
$4.39
N/A
Revenue Next Year
$3.21
$744.61
P/E Ratio
$8.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.16
$13.94
52 Week High
$58.67
$42.50

Technical Indicators

Market Signals
Indicator
HRB
ROIV
Relative Strength Index (RSI) 39.88 60.38
Support Level $42.07 $33.15
Resistance Level $47.33 $42.50
Average True Range (ATR) 1.45 1.51
MACD -1.02 0.42
Stochastic Oscillator 16.33 67.36

Price Performance

Historical Comparison
HRB
ROIV

About HRB H&R Block Inc.

H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: